In 2020, the US open surgery instrument market will be severely impacted by the COVID-19 pandemic. However, the overall market for open surgery devices in the US will exhibit moderate growth over the forecast period, driven largely by rising penetration of direct energy and closure devices in open procedures as well as the increasing adoption of premium-priced products.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for open surgery instruments in the US across a 10-year period.
The COVID-19 pandemic will affect the open surgery instrument market.
To what extent will the COVID-19 pandemic impact the open surgery instrument market in US?
Which procedures are going to be affected the most during the pandemic?
The US open surgery instrument market will grow moderately.
What factors are driving and limiting the open surgery instrument market?
Which open surgery instrument market segment will see the strongest growth in the US?
Which device segments will decline in size?
The increasing uptake of robotic-assisted laparoscopy will occur at the expense of open procedures.
Which procedures will be most affected by this trend?
Why are some procedures more affected by this trend than others?
- Open Surgery Instruments - Market Insights - United States
Author(s): Lucy Sha Guan, MSc
Lucy Guan is a senior analyst within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Decision Resources Group, with extensive knowledge in the markets for endoscope servicing, video and high-tech hardware devices, and laparoscopic devices. Lucy holds an Honors Bachelor's degree in Biochemistry and Health & Disease and a Master's degree in Medical Science from the University of Toronto.